 Pneumonia, Mycoplasma
"Pneumonia, Mycoplasma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Interstitial pneumonia caused by extensive infection of the lungs (LUNG) and BRONCHI, particularly the lower lobes of the lungs, by MYCOPLASMA PNEUMONIAE in humans. In SHEEP, it is caused by MYCOPLASMA OVIPNEUMONIAE. In CATTLE, it may be caused by MYCOPLASMA DISPAR.
| Descriptor ID |
D011019
|
| MeSH Number(s) |
C01.252.400.610.610.760 C01.252.620.500 C08.381.677.540.500 C08.730.610.540.500
|
| Concept/Terms |
Pneumonia, Mycoplasma- Pneumonia, Mycoplasma
- Pneumonia, Primary Atypical
- Atypical Pneumonia, Primary
- Atypical Pneumonias, Primary
- Pneumonias, Primary Atypical
- Primary Atypical Pneumonia
- Primary Atypical Pneumonias
- Mycoplasma Pneumonia
- Mycoplasma Pneumonias
- Pneumonias, Mycoplasma
|
Below are MeSH descriptors whose meaning is more general than "Pneumonia, Mycoplasma".
Below are MeSH descriptors whose meaning is more specific than "Pneumonia, Mycoplasma".
This graph shows the total number of publications written about "Pneumonia, Mycoplasma" by people in this website by year, and whether "Pneumonia, Mycoplasma" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 1 | 0 | 1 | | 2004 | 2 | 0 | 2 | | 2005 | 2 | 0 | 2 | | 2006 | 2 | 0 | 2 | | 2015 | 2 | 0 | 2 | | 2018 | 1 | 0 | 1 | | 2019 | 1 | 0 | 1 | | 2020 | 1 | 0 | 1 | | 2024 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Pneumonia, Mycoplasma" by people in Profiles.
-
Edens C, Clopper BR, DeVies J, Benitez A, McKeever ER, Johns D, Wolff B, Selvarangan R, Schuster JE, Weinberg GA, Szilagyi PG, Dawood FS, Radhakrishnan L, Quigley C, Sahni LC, Halasa N, Stewart LS, McMorrow ML, Whitaker B, Zerr DM, Avadhanula V, Williams JV, Michaels MG, Kite-Powell A, Englund JA, Staat MA, Hartnett K, Moline HL, Cohen AL, Diaz M. Notes from the Field: Reemergence of Mycoplasma pneumoniae Infections in Children and Adolescents After the COVID-19 Pandemic, United States, 2018-2024. MMWR Morb Mortal Wkly Rep. 2024 Feb 22; 73(7):149-151.
-
Xiao L, Ratliff AE, Crabb DM, Mixon E, Qin X, Selvarangan R, Tang YW, Zheng X, Dien Bard J, Hong T, Prichard M, Brooks E, Dallas S, Duffy LB, Fowler KB, Atkinson TP, Waites KB. Molecular Characterization of Mycoplasma pneumoniae Isolates in the United States from 2012 to 2018. J Clin Microbiol. 2020 09 22; 58(10).
-
Waites KB, Ratliff A, Crabb DM, Xiao L, Qin X, Selvarangan R, Tang YW, Zheng X, Dien Bard J, Hong T, Prichard M, Brooks E, Dallas S, Duffy L, Mixon E, Fowler KB, Atkinson TP. Macrolide-Resistant Mycoplasma pneumoniae in the United States as Determined from a National Surveillance Program. J Clin Microbiol. 2019 11; 57(11).
-
Kanwar N, Pence MA, Mayne D, Michael J, Selvarangan R. Evaluation of the illumigene Mycoplasma Direct DNA Amplification Assay. J Clin Microbiol. 2018 07; 56(7).
-
Yan C, Sun H, Lee S, Selvarangan R, Qin X, Tang YW, Waites KB, Zheng X. Comparison of Molecular Characteristics of Mycoplasma pneumoniae Specimens Collected from the United States and China. J Clin Microbiol. 2015 Dec; 53(12):3891-3.
-
Zheng X, Lee S, Selvarangan R, Qin X, Tang YW, Stiles J, Hong T, Todd K, Ratliff AE, Crabb DM, Xiao L, Atkinson TP, Waites KB. Macrolide-Resistant Mycoplasma pneumoniae, United States. Emerg Infect Dis. 2015 Aug; 21(8):1470-2.
-
Salvatore CM, Fonseca-Aten M, Katz-Gaynor K, Gomez AM, Mejias A, Somers C, Chavez-Bueno S, McCracken GH, Hardy RD. Respiratory tract infection with Mycoplasma pneumoniae in interleukin-12 knockout mice results in improved bacterial clearance and reduced pulmonary inflammation. Infect Immun. 2007 Jan; 75(1):236-42.
-
Fonseca-Aten M, Rios AM, Mejias A, Chavez-Bueno S, Katz K, Gomez AM, Ramilo O, McCracken GH, Hardy RD. Treatment of experimental chronic pulmonary mycoplasmosis. Int J Antimicrob Agents. 2006 Sep; 28(3):253-8.
-
Fonseca-Aten M, Salvatore CM, Mej?as A, R?os AM, Ch?vez-Bueno S, Katz K, G?mez AM, McCracken GH, Hardy RD. Evaluation of LBM415 (NVP PDF-713), a novel peptide deformylase inhibitor, for treatment of experimental Mycoplasma pneumoniae pneumonia. Antimicrob Agents Chemother. 2005 Oct; 49(10):4128-36.
-
R?os AM, Fonseca-Aten M, Mej?as A, Ch?vez-Bueno S, Katz K, G?mez AM, McCracken GH, Ramilo O, Hardy RD. Microbiologic and immunologic evaluation of a single high dose of azithromycin for treatment of experimental Mycoplasma pneumoniae pneumonia. Antimicrob Agents Chemother. 2005 Sep; 49(9):3970-3.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|